Cargando…

Subcutaneous implantable cardioverter defibrillator in patients awaiting cardiac transplantation or left ventricular assist device for refractory heart failure: a feasible alternative to transvenous device?

Detalles Bibliográficos
Autores principales:	Migliore, Federico, Cavalli, Giacomo, Bottio, Tomaso, De Franceschi, Pietro, Bertaglia, Emanuele, Gerosa, Gino, Iliceto, Sabino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Guest Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933964/ https://www.ncbi.nlm.nih.gov/pubmed/29377556 http://dx.doi.org/10.1002/ehf2.12255

Ejemplares similares

Hybrid minimally invasive technique with the bidirectional rotational Evolution(®) mechanical sheath for transvenous lead extraction: A collaboration between electrophysiologists and cardiac surgeons
por: Migliore, Federico, et al.
Publicado: (2018)

Comparative outcomes of subcutaneous and transvenous cardioverter-defibrillators
por: Liang, Jin-Jun, et al.
Publicado: (2019)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Multicentre experience with the second‐generation subcutaneous implantable cardioverter defibrillator and the intermuscular two‐incision implantation technique
por: Migliore, Federico, et al.
Publicado: (2019)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

Comparison of quality-of-life measures in patients with transvenous and subcutaneous implantable cardioverter-defibrillators
por: Ferrick, Aileen M., et al.
Publicado: (2023)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Subcutaneous Implantable Cardioverter‐Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience
por: Orgeron, Gabriela M., et al.
Publicado: (2018)

Comparison of complications and shocks in paediatric and young transvenous and subcutaneous implantable cardioverter-defibrillator patients
por: Quast, A. B. E., et al.
Publicado: (2018)

Eligibility for subcutaneous implantable cardioverter-defibrillator in patients with left ventricular assist device
por: Zormpas, Christos, et al.
Publicado: (2020)

Epicardial vs. transvenous implantable cardioverter defibrillators in children
por: Le Bos, Pierre Antoine, et al.
Publicado: (2023)

Transvenous vs. subcutaneous ICDs after transvenous device complication
por: Willy, K, et al.
Publicado: (2023)

De novo subcutaneous implantable cardioverter-defibrillator in patient with left ventricular assist device
por: Reichert, William, et al.
Publicado: (2020)

Subcutaneous implantable cardioverter‐defibrillator noise following left ventricular assist device implantation
por: Khetarpal, Banveet Kaur, et al.
Publicado: (2023)

Inappropriate device sensing in a subcutaneous implantable cardioverter-defibrillator resulting in early battery depletion
por: Sullivan, Malachy, et al.
Publicado: (2023)

The “Defibrillation Testing, Why Not?” survey. Testing of subcutaneous and transvenous defibrillators in the Italian clinical practice()
por: Migliore, Federico, et al.
Publicado: (2022)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Implantable cardioverter-defibrillator in patients awaiting heart transplantation: Reinforcing the bridge to transplant
por: Ariyaratnam, Jonathan P., et al.
Publicado: (2021)

Intermuscular two-incision technique for implantation of the subcutaneous implantable defibrillator: 3-year follow-up
por: Migliore, F, et al.
Publicado: (2023)

Forces Applied during Transvenous Implantable Cardioverter Defibrillator Lead Removal
por: Lennerz, Carsten, et al.
Publicado: (2014)

Transvenous Implantable Cardioverter-Defibrillator Lead Reliability: Implications for Postmarket Surveillance
por: Kramer, Daniel B, et al.
Publicado: (2015)

State‐of‐the‐art consensus on non‐transvenous implantable cardioverter‐defibrillator therapy
por: Schukro, Christoph, et al.
Publicado: (2020)

Dental management of a patient fitted with subcutaneous Implantable Cardioverter Defibrillator device and concomitant warfarin treatment
por: Shah, Altaf Hussain, et al.
Publicado: (2015)

Subcutaneous implantable cardioverter defibrillators in patients with left ventricular assist devices: case report and comprehensive review
por: López-Gil, María, et al.
Publicado: (2019)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

Lead Abandonment and Subcutaneous Implantable Cardioverter-Defibrillator (S-ICD) Implantation in a Cohort of Patients With ICD Lead Malfunction
por: Russo, Vincenzo, et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Subcutaneous Implantable Cardioverter Defibrillator: Early Experience
por: Souza, Fernando Sérgio Oliva, et al.
Publicado: (2017)

Successful management of wound dehiscence after implantation of a subcutaneous implantable cardioverter-defibrillator without device removal
por: Fukata, Mitsuhiro, et al.
Publicado: (2017)

Validity of device-measured activity in patients with an implantable cardioverter-defibrillator
por: Kolk, M Z H, et al.
Publicado: (2023)

Screening of unknown atrial fibrillation through handheld device in the elderly
por: Rivezzi, Francesco, et al.
Publicado: (2020)

Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or subcutaneous defibrillator
por: Francia, Pietro, et al.
Publicado: (2023)

Device-Related Complications and Inappropriate Therapies Among Subcutaneous vs. Transvenous Implantable Defibrillator Recipients: Insight Monaldi Rhythm Registry
por: Russo, Vincenzo, et al.
Publicado: (2022)

Lead failure in transvenous implantable cardioverter defibrillator: a new opportunity for an effective management
por: Pignalberi, Carlo, et al.
Publicado: (2018)

Transvenous shock‐only implantable cardioverter defibrillator after an atrio‐pulmonary Fontan surgery
por: Toyohara, Keiko, et al.
Publicado: (2020)

The subcutaneous implantable cardioverter defibrillator––review of the recent data
por: Westerman, Stacy B, et al.
Publicado: (2018)

Subcutaneous Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
por: Ip, James E.
Publicado: (2017)

An “UninTENSional” Subcutaneous Implantable Cardioverter-defibrillator Shock
por: Turner, Suzette L., et al.
Publicado: (2018)

Inappropriate subcutaneous implantable cardioverter-defibrillator shocks for bradycardia
por: Chua, Kelvin C.M., et al.
Publicado: (2021)

Painful detour of subcutaneous implantable cardioverter-defibrillator lead
por: Bisson, Jasmine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5ue1tqgkk2oi37nqa9t4d968q7